Biovie (BIVI) Operating Leases (2022 - 2026)
Biovie (BIVI) posted Operating Leases of $213319.0 for Q1 2026, down 8.26% sequentially from $232517.0 in Q4 2025, and down 27.86% YoY from $295717.0 in Q1 2025.
Biovie (BIVI) Operating Leases (2022 - 2026) Analysis & Trends
Biovie has reported Operating Leases for 5 years, with the latest figure at $213319.0 in Q1 2026.
- Quarterly Operating Leases fell 27.86% year-over-year to $213319.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $213319.0 (down 27.86% YoY) and the FY2025 annual result came in at $275430.0, down 21.28% from the prior year.
- Operating Leases slipped to $213319.0 in Q1 2026 per BIVI's latest filing, from $232517.0 in the prior quarter.
- Over five years, Operating Leases peaked at $366430.0 in Q1 2024 and troughed at $17604.0 in Q4 2023.
- A 5-year average of $189825.2 and a median of $213319.0 in 2026 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2024: Operating Leases tumbled 73.26% in 2023, then surged 1688.88% in 2024.
- Over 5 years, Operating Leases stood at $65835.0 in 2022, then sank by 73.26% to $17604.0 in 2023, then soared by 1688.88% to $314915.0 in 2024, then slipped by 26.17% to $232517.0 in 2025, then decreased by 8.26% to $213319.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $213319.0, $232517.0, and $254373.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 184,421.00 |
| Mar 31, 2026 | 213,319.00 |
| Dec 31, 2025 | 232,517.00 |
| Sep 30, 2025 | 254,373.00 |
| Jun 30, 2025 | 275,430.00 |
| Mar 31, 2025 | 295,717.00 |
| Dec 31, 2024 | 314,915.00 |
| Sep 30, 2024 | 332,730.00 |
| Jun 30, 2024 | 349,894.00 |
| Mar 31, 2024 | 366,430.00 |
| Dec 31, 2023 | 17,604.00 |
| Sep 30, 2023 | 76,769.00 |
| Jun 30, 2023 | 42,505.00 |
| Mar 31, 2023 | 97,779.00 |
| Dec 31, 2022 | 65,835.00 |
| Sep 30, 2022 | 76,768.00 |
| Jun 30, 2022 | 87,414.00 |
| Mar 31, 2022 | 127,029.00 |